Ilse van de Vondervoort1, Geert Poelmans1, Armaz Aschrafi1, David L Pauls1, Jan K Buitelaar1, Jeffrey C Glennon1, Barbara Franke1. 1. From the Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands (van de Vondervoort, Poelmans, Buitelaar, Glennon); the Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands (Poelmans, Franke); the Department of Molecular Animal Physiology, Donders Institute for Brain, Cognition and Behaviour, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University, Nijmegen, The Netherlands (Poelmans); the Department of Neuroinformatics, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands (Aschrafi); the Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA (Pauls); the Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands (Franke); and the Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands (Buitelaar).
Abstract
BACKGROUND: Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with onset in childhood and is characterized by obsessions (recurrent, intrusive, persistent thoughts, impulses and/or ideas that often cause anxiety or distress) and compulsions (ritualized and stereotypic behaviours or mental acts that are often performed to relieve anxiety or distress associated with obsessions). Although OCD is a heritable disorder, its complex molecular etiology is poorly understood. METHODS: We combined enrichment analyses and an elaborate literature review of the top-ranked genes emerging from the 2 published genome-wide association studies of OCD and candidate genes implicated through other evidence in order to identify biological processes that, when dysregulated, increase the risk for OCD. RESULTS: The resulting molecular protein landscape was enriched for proteins involved in regulating postsynaptic dendritic spine formation - and hence synaptic plasticity - through insulin-dependent molecular signalling cascades. LIMITATIONS: This study is a first attempt to integrate molecuar information from different sources in order to identify biological mechanisms underlying OCD etiology. Our findings are constrained by the limited information from hypothesis-free studies and the incompleteness and existing limitations of the OCD literature and the gene function annotations of gene enrichment tools. As this study was solely based on in silico analyses, experimental validation of the provided hypotheses is warranted. CONCLUSION: Our work suggests a key role for insulin and insulin-related signalling in OCD etiology and - if confirmed by independent studies - could eventually pave the way for the development of novel OCD treatments.
BACKGROUND:Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with onset in childhood and is characterized by obsessions (recurrent, intrusive, persistent thoughts, impulses and/or ideas that often cause anxiety or distress) and compulsions (ritualized and stereotypic behaviours or mental acts that are often performed to relieve anxiety or distress associated with obsessions). Although OCD is a heritable disorder, its complex molecular etiology is poorly understood. METHODS: We combined enrichment analyses and an elaborate literature review of the top-ranked genes emerging from the 2 published genome-wide association studies of OCD and candidate genes implicated through other evidence in order to identify biological processes that, when dysregulated, increase the risk for OCD. RESULTS: The resulting molecular protein landscape was enriched for proteins involved in regulating postsynaptic dendritic spine formation - and hence synaptic plasticity - through insulin-dependent molecular signalling cascades. LIMITATIONS: This study is a first attempt to integrate molecuar information from different sources in order to identify biological mechanisms underlying OCD etiology. Our findings are constrained by the limited information from hypothesis-free studies and the incompleteness and existing limitations of the OCD literature and the gene function annotations of gene enrichment tools. As this study was solely based on in silico analyses, experimental validation of the provided hypotheses is warranted. CONCLUSION: Our work suggests a key role for insulin and insulin-related signalling in OCD etiology and - if confirmed by independent studies - could eventually pave the way for the development of novel OCD treatments.
Authors: M Karayiorgou; C Sobin; M L Blundell; B L Galke; L Malinova; P Goldberg; J Ott; J A Gogos Journal: Biol Psychiatry Date: 1999-05-01 Impact factor: 13.382
Authors: Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore Journal: Neurosci Biobehav Rev Date: 2007-10-17 Impact factor: 8.989
Authors: Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii Journal: Nat Med Date: 2010-04-25 Impact factor: 53.440
Authors: S E Stewart; D Yu; J M Scharf; B M Neale; J A Fagerness; C A Mathews; P D Arnold; P D Evans; E R Gamazon; L K Davis; L Osiecki; L McGrath; S Haddad; J Crane; D Hezel; C Illman; C Mayerfeld; A Konkashbaev; C Liu; A Pluzhnikov; A Tikhomirov; C K Edlund; S L Rauch; R Moessner; P Falkai; W Maier; S Ruhrmann; H-J Grabe; L Lennertz; M Wagner; L Bellodi; M C Cavallini; M A Richter; E H Cook; J L Kennedy; D Rosenberg; D J Stein; S M J Hemmings; C Lochner; A Azzam; D A Chavira; E Fournier; H Garrido; B Sheppard; P Umaña; D L Murphy; J R Wendland; J Veenstra-VanderWeele; D Denys; R Blom; D Deforce; F Van Nieuwerburgh; H G M Westenberg; S Walitza; K Egberts; T Renner; E C Miguel; C Cappi; A G Hounie; M Conceição do Rosário; A S Sampaio; H Vallada; H Nicolini; N Lanzagorta; B Camarena; R Delorme; M Leboyer; C N Pato; M T Pato; E Voyiaziakis; P Heutink; D C Cath; D Posthuma; J H Smit; J Samuels; O J Bienvenu; B Cullen; A J Fyer; M A Grados; B D Greenberg; J T McCracken; M A Riddle; Y Wang; V Coric; J F Leckman; M Bloch; C Pittenger; V Eapen; D W Black; R A Ophoff; E Strengman; D Cusi; M Turiel; F Frau; F Macciardi; J R Gibbs; M R Cookson; A Singleton; J Hardy; A T Crenshaw; M A Parkin; D B Mirel; D V Conti; S Purcell; G Nestadt; G L Hanna; M A Jenike; J A Knowles; N Cox; D L Pauls Journal: Mol Psychiatry Date: 2012-08-14 Impact factor: 15.992
Authors: Jilly Naaijen; Saskia de Ruiter; Marcel P Zwiers; Jeffrey C Glennon; Sarah Durston; David J Lythgoe; Steven C R Williams; Tobias Banaschewski; Daniel Brandeis; Barbara Franke; Jan K Buitelaar Journal: BMC Psychiatry Date: 2016-10-26 Impact factor: 3.630
Authors: Claudio Toma; Alex D Shaw; Richard J N Allcock; Anna Heath; Kerrie D Pierce; Philip B Mitchell; Peter R Schofield; Janice M Fullerton Journal: Transl Psychiatry Date: 2018-03-13 Impact factor: 6.222
Authors: J E Visser; G Poelmans; C J H M Klemann; G J M Martens; M Sharma; M B Martens; O Isacson; T Gasser Journal: NPJ Parkinsons Dis Date: 2017-04-10
Authors: J Bralten; K J van Hulzen; M B Martens; T E Galesloot; A Arias Vasquez; L A Kiemeney; J K Buitelaar; J W Muntjewerff; B Franke; G Poelmans Journal: Mol Psychiatry Date: 2017-05-16 Impact factor: 15.992
Authors: Ilse I G M van de Vondervoort; Houshang Amiri; Muriel M K Bruchhage; Charlotte A Oomen; Nitin Rustogi; Jason D Cooper; Jack J A van Asten; Arend Heerschap; Sabine Bahn; Steven C R Williams; Jan K Buitelaar; Geert Poelmans; Jeffrey C Glennon Journal: Transl Psychiatry Date: 2019-09-12 Impact factor: 6.222
Authors: Janita Bralten; Joanna Widomska; Barbara Franke; Geert Poelmans; Ward De Witte; Dongmei Yu; Carol A Mathews; Jeremiah M Scharf; Jan Buitelaar; Jennifer Crosbie; Russell Schachar; Paul Arnold; Mathieu Lemire; Christie L Burton Journal: Transl Psychiatry Date: 2020-04-27 Impact factor: 6.222
Authors: Sylvia Nieuwenhuis; Kees Okkersen; Joanna Widomska; Paul Blom; Peter A C 't Hoen; Baziel van Engelen; Jeffrey C Glennon Journal: Front Neurol Date: 2019-11-26 Impact factor: 4.003
Authors: Natalie J Forde; Ahmad S Kanaan; Joanna Widomska; Shanmukha S Padmanabhuni; Ester Nespoli; John Alexander; Juan I Rodriguez Arranz; Siyan Fan; Rayan Houssari; Muhammad S Nawaz; Francesca Rizzo; Luca Pagliaroli; Nuno R Zilhäo; Tamas Aranyi; Csaba Barta; Tobias M Boeckers; Dorret I Boomsma; Wim R Buisman; Jan K Buitelaar; Danielle Cath; Andrea Dietrich; Nicole Driessen; Petros Drineas; Michelle Dunlap; Sarah Gerasch; Jeffrey Glennon; Bastian Hengerer; Odile A van den Heuvel; Cathrine Jespersgaard; Harald E Möller; Kirsten R Müller-Vahl; Thaïra J C Openneer; Geert Poelmans; Petra J W Pouwels; Jeremiah M Scharf; Hreinn Stefansson; Zeynep Tümer; Dick J Veltman; Ysbrand D van der Werf; Pieter J Hoekstra; Andrea Ludolph; Peristera Paschou Journal: Front Neurosci Date: 2016-08-23 Impact factor: 4.677